NanoVibronix, Inc. (NAOV): Price and Financial Metrics

NanoVibronix, Inc. (NAOV): $1.97

0.16 (-7.51%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

NAOV Price/Volume Stats

Current price $1.97 52-week high $12.90
Prev. close $2.13 52-week low $1.41
Day low $1.93 Volume 50,600
Day high $2.11 Avg. volume 558,384
50-day MA $2.55 Dividend yield N/A
200-day MA $3.89 Market Cap 3.27M

NAOV Stock Price Chart Interactive Chart >

NAOV Stock Summary

  • NAOV has a higher market value than merely 2.1% of US stocks; more precisely, its current market capitalization is $3,873,229.
  • For NAOV, its debt to operating expenses ratio is greater than that reported by just 4.78% of US equities we're observing.
  • Revenue growth over the past 12 months for NANOVIBRONIX INC comes in at -68.34%, a number that bests merely 3.23% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to NANOVIBRONIX INC, a group of peers worth examining would be AQB, BOXL, AOUT, TRT, and CYAN.
  • NAOV's SEC filings can be seen here. And to visit NANOVIBRONIX INC's official web site, go to www.nanovibronix.com.

NAOV Valuation Summary

  • In comparison to the median Healthcare stock, NAOV's price/sales ratio is 221.05% higher, now standing at 6.1.
  • Over the past 101 months, NAOV's price/sales ratio has gone down 38.7.

Below are key valuation metrics over time for NAOV.

Stock Date P/S P/B P/E EV/EBIT
NAOV 2023-09-22 6.1 3.3 -0.8 -0.8
NAOV 2023-09-21 6.5 3.6 -0.8 -0.9
NAOV 2023-09-20 6.7 3.7 -0.8 -0.9
NAOV 2023-09-19 6.8 3.8 -0.8 -0.9
NAOV 2023-09-18 7.0 3.9 -0.9 -0.9
NAOV 2023-09-15 7.3 4.0 -0.9 -1.0

NAOV Growth Metrics

    Its 2 year cash and equivalents growth rate is now at 1252.14%.
  • The 3 year net cashflow from operations growth rate now stands at -42.38%.
  • Its 3 year price growth rate is now at -78.91%.
NAOV's revenue has moved up $1,296,000 over the prior 49 months.

The table below shows NAOV's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 1.629 -6.567 -5.863
2022-06-30 2.031 -5.237 -11.583
2022-03-31 1.864 -5.154 -10.497
2021-12-31 1.695 -4.367 -14.282
2021-09-30 1.01 -4.822 -12.813
2021-06-30 0.661 -4.883 -7.06

NAOV's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • NAOV has a Quality Grade of D, ranking ahead of 5.54% of graded US stocks.
  • NAOV's asset turnover comes in at 0.095 -- ranking 154th of 186 Medical Equipment stocks.
  • NUWE, SIEN, and ATRS are the stocks whose asset turnover ratios are most correlated with NAOV.

The table below shows NAOV's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.095 0.620 20.273
2021-03-31 0.112 0.392 13.158
2020-12-31 0.172 0.343 8.655
2020-09-30 0.300 0.261 -32.726
2020-06-30 0.316 0.193 -30.341
2020-06-30 0.316 0.193 -30.341

NanoVibronix, Inc. (NAOV) Company Bio


NanoVibronix, Inc. operates as a medical device company. The Company focuses on non-invasive biological response-activating devices that target wound healing and pain therapy. NanoVibronix develops medical devices based on its proprietary therapeutic ultrasound technology.


NAOV Latest News Stream


Event/Time News Detail
Loading, please wait...

NAOV Latest Social Stream


Loading social stream, please wait...

View Full NAOV Social Stream

Latest NAOV News From Around the Web

Below are the latest news stories about NANOVIBRONIX INC that investors may wish to consider to help them evaluate NAOV as an investment opportunity.

NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting

ELMSFORD, N.Y., September 06, 2023--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that Dr. Sandra Wilks is scheduled to present the findings from her study of UroShield® at the International Continence Society (ICS) 2023 Conference in Toronto on Wednesday, September 27.

Yahoo | September 6, 2023

Dear ACHR Stock Fans, Mark Your Calendars for Sept. 12

Archer Aviation (ACHR) stock fans will want to keep an eye on the urban air mobility company when Sept. 12, 2023, rolls around!

William White on InvestorPlace | August 30, 2023

Why Is NanoVibronix (NAOV) Up 153% Today?

NanoVibronix (NAOV) stock is climbing higher on Wednesday after releasing independent results from a study of its UroShield medical device.

William White on InvestorPlace | August 30, 2023

NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

ELMSFORD, N.Y., August 30, 2023--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 2,906,977 shares of its common stock (or common stock equivalents in lieu thereof), series A-1 warrants to purchase up to 2,906,977 shares of common stock and series A-2

Yahoo | August 30, 2023

Why Is NanoVibronix Stock Trading Higher Today?

NanoVibronix Inc (NASDAQ: NAOV) reported outcomes from a UroShield study conducted at the University of Southampton in the U.K. Quantitative data from the research indicated a positive effect of UroShield on catheter-associated urinary tract infections (CAUTI) and catheter blockage, with approximately one-third of patients in the study citing a reduction in the frequency of catheter blockages and the need for unscheduled catheter challenges. Furthermore, qualitative data indicated favorable opin

Yahoo | August 30, 2023

Read More 'NAOV' Stories Here

NAOV Price Returns

1-mo -20.24%
3-mo -42.57%
6-mo -42.05%
1-year -78.59%
3-year -85.93%
5-year -97.88%
YTD -60.91%
2022 -75.77%
2021 36.11%
2020 -73.19%
2019 -21.27%
2018 -22.65%

Continue Researching NAOV

Here are a few links from around the web to help you further your research on NanoVibronix Inc's stock as an investment opportunity:

NanoVibronix Inc (NAOV) Stock Price | Nasdaq
NanoVibronix Inc (NAOV) Stock Quote, History and News - Yahoo Finance
NanoVibronix Inc (NAOV) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!